Literature DB >> 659630

Factors influencing the handling of insulin by the isolated rat kidney.

R Rabkin, A E Kitabchi.   

Abstract

The renal handling of immunoreactive insulin was studied in the isolated perfused normothermic rat kidney to determine (a) the relative contributions of glomerular clearance and peritubular clearance to the renal clearance of insulin under different conditions, (b) what metabolic factors influence the ability of tubular cells to remove insulin from the glomerular filtrate and the peritubular circulation, and (c) whether the same factors influence the luminal and contraluminal uptake of insulin.In control kidneys the organ clearance of insulin (OCi) was 974+/-63 mul/min (SEM), of which a maximum of 46% could theoretically be accounted for by filtration. OCi was not altered by fasting, lack of exogenous fuel (glucose), or the addition of cyanide. The glomerular filtration rate did not correlate with the OCi, but there was a significant (P < 0.001) negative correlation (r = -0.828) between the peritubular clearance and glomerular filtration rate. Both N-ethylmaleimide and cold (10 degrees C) reduced the rate of insulin removal. Fractional excretion of filtered insulin (9.7+/-1.7% in controls) was not significantly altered by fasting or perfusing without glucose. In contrast, KCN increased fractional excretion of insulin to 41.9+/-3.7% whereas cold increased fractional excretion to 69.0+/-3.3%. This study indicates that renal tubular cells remove insulin from the tubular lumen and the peritubular compartment. Furthermore, the data suggest that insulin removal by tubular cells is a temperature-sensitive process consisting of two different systems. The system associated with the luminal aspect of the cell appears to be dependent on oxidative metabolism, whereas the system associated with the contraluminal aspects of the cell appears to be independent thereof. Under several circumstances when the glomerular clearance of insulin falls thereby reducing the amount of insulin absorbed by the luminal aspect of the cell, contraluminal uptake increases, and a constant rate of insulin removal is maintained by the kidney.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659630      PMCID: PMC371750          DOI: 10.1172/JCI109102

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Insulin and glucagon degradation by the kidney. II. Characterization of the mechanisms at neutral pH.

Authors:  W C Duckworth
Journal:  Biochim Biophys Acta       Date:  1976-07-21

2.  Studies on the mechanism of capture and degradation of insulin-1131 by the cyclically perfused rat liver.

Authors:  G E MORTIMORE; F TIETZE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  Metabolism of insulin-I 131 and glucagon-I 131 in the kidney of the rat.

Authors:  H T NARAHARA; N B EVERETT; B S SIMMONS; R H WILLIAMS
Journal:  Am J Physiol       Date:  1958-02

4.  Radioreceptor assay for insulin.

Authors:  K Suzuki; N Ohsawa; K Kosaka
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

5.  Binding and degradation of insulin by human peripheral granulocytes. Demonstration of specific receptors with high affinity.

Authors:  R D Fussganger; C R Kahn; J Roth; P De Meyts
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

Review 6.  The role of the kidney in the metabolism of plasma proteins.

Authors:  W Strober; T A Waldmann
Journal:  Nephron       Date:  1974       Impact factor: 2.847

7.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

Authors:  B I Posner; P A Kelly; R P Shiu; H G Friesen
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

8.  Degradation of insulin and proinsulin by various organ homogenates of rat.

Authors:  A E Kitabchi; F B Stentz
Journal:  Diabetes       Date:  1972-11       Impact factor: 9.461

9.  Metabolic activities of the isolated perfused rat kidney.

Authors:  J M Nishiitsutsuji-Uwo; B D Ross; H A Krebs
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

10.  Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme.

Authors:  A E Kitabchi; W C Duckworth; J S Brush; M Heinemann
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

View more
  8 in total

1.  In vivo imaging of insulin receptors in monkeys using 18F-labeled insulin and positron emission tomography.

Authors:  R C Eastman; R E Carson; K A Jacobson; Y Shai; M A Channing; B B Dunn; J D Bacher; E Baas; E Jones; K L Kirk
Journal:  Diabetes       Date:  1992-07       Impact factor: 9.461

2.  Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.

Authors:  K S Polonsky; J B Jaspan; M Berelowitz; D S Emmanouel; J Dhorajiwala
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

3.  The handling of immunoreactive vasopressin by the isolated perfused rat kidney.

Authors:  R Rabkin; L Share; P A Payne; J Young; J Crofton
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

Review 4.  Catabolism of interferons.

Authors:  V Bocci
Journal:  Surv Immunol Res       Date:  1982

5.  Renal handling of homologous and heterologous insulin in the isolated perfused rat kidney.

Authors:  E Schlatter; H J Schurek; R Zick
Journal:  Pflugers Arch       Date:  1982-05       Impact factor: 3.657

6.  Insulin binding and degradation by luminal and basolateral tubular membranes from rabbit kidney.

Authors:  Z Talor; D S Emmanouel; A I Katz
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

Review 7.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

8.  Tubular Secretory Clearance Is Associated With Whole-Body Insulin Clearance.

Authors:  Matthew P Huber; Leila R Zelnick; Kristina M Utzschneider; Steven E Kahn; Ian H de Boer; Bryan R Kestenbaum
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.